#100000
Looking for work <a href=" http://pharmatory.com/facilities/#rag ">benazepril online prices</a> Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group(TM), with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that Diagnoplex has secured 1.3 million Swiss francs from a financing round led by Debiopharm.
Submitted by Anonymous (not verified) on Wed, 10/22/2014 - 14:59 to Relationships |
